Overview
Chronic milk alkali syndrome (CMAS) is a rare but potentially serious condition characterized by hypercalcemia, metabolic alkalosis, and renal impairment, typically resulting from prolonged ingestion of calcium-containing antacids, particularly those containing calcium carbonate and aluminum hydroxide, often mixed with milk. This syndrome was more prevalent in the mid-20th century with the widespread use of these antacids but remains relevant due to occasional misuse or overuse in contemporary clinical settings. The pathophysiology involves complex interactions between calcium metabolism, acid-base balance, and renal function, leading to systemic manifestations that require prompt recognition and management to prevent severe complications.
Pathophysiology
The core pathophysiological mechanism in chronic milk alkali syndrome revolves around the excessive intake of calcium and alkali, primarily from calcium-containing antacids combined with milk. The study by [PMID:10483803] demonstrated that chronic ingestion of sodium bicarbonate over a 5-day period significantly elevated blood pH and bicarbonate levels, increasing from 22.8 (0.4) to 28.4 (1.1) mmol/L. This metabolic alkalosis parallels the disturbances seen in CMAS, where sustained hypercalcemia and alkalosis disrupt normal physiological processes. The elevated bicarbonate levels lead to a leftward shift in the oxygen-hemoglobin dissociation curve, potentially affecting tissue oxygenation. Additionally, the high calcium load overwhelms the renal excretory capacity, leading to hypercalciuria and subsequent nephrocalcinosis. Over time, these renal calcifications can impair renal function, contributing to the characteristic renal failure seen in severe cases of CMAS. The interplay between hypercalcemia and metabolic alkalosis exacerbates bone demineralization, further complicating the clinical picture with symptoms such as bone pain and fractures.
Clinical Presentation
Patients with chronic milk alkali syndrome often present with a constellation of symptoms reflecting the systemic impact of hypercalcemia and metabolic disturbances. While the cited study [PMID:10483803] noted improved performance during high-intensity exercise post-bicarbonate supplementation, this finding is more indicative of acute metabolic adaptations rather than the chronic manifestations of CMAS. In clinical practice, patients typically exhibit nonspecific symptoms such as fatigue, weakness, nausea, and abdominal pain, which can be attributed to both the metabolic disturbances and gastrointestinal irritation from prolonged antacid use. More specific signs include polyuria and polydipsia due to nephrogenic diabetes insipidus secondary to hypercalcemia, and neurological symptoms like confusion or depression, reflecting the impact of altered calcium homeostasis on brain function. Renal involvement manifests as flank pain, hematuria, and signs of renal failure, including oliguria or anuria. Bone symptoms, including bone pain and fractures, are also common due to the demineralizing effects of hypercalcemia. Early recognition of these symptoms is crucial for timely intervention to prevent irreversible organ damage.
Diagnosis
Diagnosing chronic milk alkali syndrome involves a comprehensive evaluation that integrates clinical history, laboratory findings, and imaging studies. A detailed patient history is essential, focusing on the duration and quantity of calcium-containing antacid use, particularly when combined with milk. Laboratory investigations typically reveal elevated serum calcium levels, often accompanied by increased ionized calcium, which is critical for diagnosis. Metabolic alkalosis is confirmed by measuring blood gas parameters, showing elevated bicarbonate levels and decreased carbon dioxide tension (PaCO2). Urinalysis may show hypercalciuria and nephrocalcinosis, which can be further elucidated through imaging studies such as ultrasound or CT scans. Renal ultrasound can reveal calcifications and structural changes indicative of chronic renal involvement. Additionally, bone density scans or X-rays might highlight signs of osteomalacia or fractures secondary to bone demineralization. Electrocardiogram (ECG) findings may include prolonged QT intervals due to hypocalciuric hypercalcemia, although this is less common in CMAS compared to acute hypercalcemia scenarios. Early and accurate diagnosis hinges on integrating these clinical and laboratory clues to differentiate CMAS from other causes of hypercalcemia and metabolic disturbances.
Management
The management of chronic milk alkali syndrome focuses on discontinuing the offending agent, correcting metabolic imbalances, and addressing organ-specific complications. Given the study by [PMID:10483803] highlighted the significant rise in blood bicarbonate levels during chronic bicarbonate supplementation, it underscores the critical importance of monitoring acid-base parameters closely in clinical settings. Immediate cessation of calcium-containing antacids and milk is paramount to halt further calcium and alkali intake. Fluid management is crucial, particularly in managing hypercalcemia and metabolic alkalosis. Intravenous hydration with normal saline can help correct dehydration and support renal function, while careful monitoring of electrolytes is essential to guide fluid therapy adjustments. In cases of severe hypercalcemia, bisphosphonates like intravenous pamidronate may be considered to reduce bone resorption and lower serum calcium levels more rapidly. Renal protection is a key concern, and close monitoring of renal function through serum creatinine, electrolytes, and urine output is necessary. If nephrocalcinosis progresses to acute kidney injury, dialysis might be required. Symptomatic relief and supportive care, including pain management for bone symptoms and psychiatric support for cognitive disturbances, are also integral parts of the management plan. Regular follow-up with repeat laboratory assessments and imaging studies helps track recovery and manage long-term complications effectively.
Key Recommendations
These recommendations aim to mitigate the systemic effects of chronic milk alkali syndrome and promote effective recovery while preventing long-term organ damage.
References
1 McNaughton L, Backx K, Palmer G, Strange N. Effects of chronic bicarbonate ingestion on the performance of high-intensity work. European journal of applied physiology and occupational physiology 1999. link
1 papers cited of 10 indexed.